1. Home
  2. DAKT vs JANX Comparison

DAKT vs JANX Comparison

Compare DAKT & JANX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Daktronics Inc.

DAKT

Daktronics Inc.

HOLD

Current Price

$20.13

Market Cap

872.1M

Sector

Industrials

ML Signal

HOLD

Logo Janux Therapeutics Inc.

JANX

Janux Therapeutics Inc.

HOLD

Current Price

$13.58

Market Cap

790.3M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAKT
JANX
Founded
1968
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Office Equipment/Supplies/Services
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
872.1M
790.3M
IPO Year
1996
2021

Fundamental Metrics

Financial Performance
Metric
DAKT
JANX
Price
$20.13
$13.58
Analyst Decision
Strong Buy
Analyst Count
0
11
Target Price
N/A
$53.60
AVG Volume (30 Days)
602.4K
784.8K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$608,932,000.00
$10,000,000.00
Revenue This Year
$13.76
N/A
Revenue Next Year
$7.35
$209.90
P/E Ratio
$28.07
N/A
Revenue Growth
6.89
N/A
52 Week Low
$10.95
$12.12
52 Week High
$28.27
$35.34

Technical Indicators

Market Signals
Indicator
DAKT
JANX
Relative Strength Index (RSI) 30.28 46.12
Support Level $18.53 $13.01
Resistance Level $20.50 $13.79
Average True Range (ATR) 1.12 0.55
MACD -0.75 0.07
Stochastic Oscillator 0.59 37.58

Price Performance

Historical Comparison
DAKT
JANX

About DAKT Daktronics Inc.

Daktronics Inc designs and manufactures electronic scoreboards, programmable display systems, and large-screen video displays for sporting, commercial, and transportation applications. It is engaged in a full range of activities: marketing and sales, engineering and product design and development, manufacturing, technical contracting, professional services, and customer service and support. The company offers a complete line of products, from small scoreboards and electronic displays to large multimillion-dollar video display systems as well as related control, timing, and sound systems. The company has five reportable segments: Commercial, Live Events, High School Park and Recreation, Transportation, and International. The company makes the majority of its revenue from Live events.

About JANX Janux Therapeutics Inc.

Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.

Share on Social Networks: